Posted by Center for Individualized Medicine (@samuelsmith5209) · Thu, Feb 27 at 12:10pm CST
Implementation of Preemptive Pharmacogenetics
Speaking at the Individualized Medicine Conference in 2013, Mary V. Relling, Pharm.D. examines the clinical practice and implementation on creating the process to preemptively screen for the right drugs for the right patients at the right time.
Dr. Relling is one of the principal investigators within the National Institutes of Health Pharmacogenomics Research Network and co-founder of the Clinical Pharmacogenetics Implementation Consortium.